We are analyzing https://link.springer.com/article/10.1007/s10495-010-0516-6.

Title:
Mechanisms of failed apoptotic cell clearance by phagocyte subsets in cardiovascular disease | Apoptosis
Description:
Recent evidence in humans indicate that defective phagocytic clearance of dying cells is linked to progression of advanced atherosclerotic lesions, the precursor to atherothrombosis, ischemic heart disease, and leading cause of death in the industrialized world. During atherogenesis, apoptotic cell turnover in the vascular wall is counterbalanced by neighboring phagocytes with high clearance efficiency, thereby limiting cellularity and maintaining lesion integrity. However, as lesions mature, phagocytic removal of apoptotic cells (efferocytosis) becomes defective, leading to secondary necrosis, expansion of plaque necrotic cores, and susceptibility to rupture. Recent genetic causation studies in experimental rodents have implicated key molecular regulators of efferocytosis in atherosclerotic progression. These include MER tyrosine kinase (MERTK), milk fat globule-EGF factor 8 (MFGE8), and complement C1q. At the cellular level, atheromata are infiltrated by a heterogenous population of professional phagocytes, comprised of monocytes, differentiated macrophages, and CD11c+ dendritic-like cells. Each cell type is characterized by disparate clearance efficiencies and varying activities of key phagocytic signaling molecules. It is in this context that we outline a working model whereby plaque necrosis and destabilization is jointly promoted by (1) direct inhibition of core phagocytic signaling pathways and (2) expansion of phagocyte subsets with poor clearance capacity. Towards identifying targets for promoting efficient apoptotic cell clearance and resolving inflammation in atherosclerosis and during ischemic heart disease and post myocardial infarction, this review will discuss potential in vivo suppressors of efferocytosis at each stage of clearance and how these putative interventional targets may differentially affect uptake at the level of vascular phagocyte subsets.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Education
Science
Telecommunications

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

The income method remains a mystery to us.

Not all websites are made for profit; some exist to inform or educate users. Or any other reason why people make websites. And this might be the case. Link.springer.com might be plotting its profit, but the way they're doing it isn't detectable yet.

Keywords {🔍}

google, scholar, pubmed, cas, article, cells, apoptotic, cell, macrophages, phagocytosis, macrophage, biol, clearance, apoptosis, atherosclerosis, immunol, dendritic, human, receptor, atherosclerotic, death, tabas, nature, calcium, plaque, arterioscler, thromb, vasc, nat, engulfment, activation, phagocyte, thorp, phagocytic, mice, van, disease, phagocytes, efferocytosis, factor, inflammation, libby, henson, usa, med, invest, wang, neutrophils, subsets, lesions,

Topics {✒️}

anti-apoptotic mediator sphingosine-1-phosphate growth arrest-specific gene month download article/chapter c-fms gene expression human aminoacyl-trna synthetase t-cell apoptosis detected dendritic cell-derived exosomes aspirin-triggered epi-lipoxins actin-bundling protein fascin �charge-sensitive” recognition mechanism elmo/dock180/rac module calcium-promoted ras inactivator s100a9 calcium-binding protein pro-resolution lipid mediators links draper-mediated phagocytosis fcgamma receptor-mediated phagocytosis apolipoprotein e-deficient mice suppresses tlr responses full article pdf article apoptosis aims induces macrophage spreading nuclear receptor lxr de meyer gr improves insulin resistance adverse prognostic factor monocyte chemotactic factor privacy choices/manage cookies cardiovascular disease apoptosis ischemic heart disease acute coronary syndromes high clearance efficiency immature dendritic cells apoptotic cell-induced odegaard ji macrophage apoptosis induced bile acid metabolism dendritic cell maturation cytosolic free calcium amorim-dias ma intracellular free calcium phagocytes promoting binding subendothelial lipoprotein retention secondary necrosis lipopolysaccharide-cd14 pathway dock180-elmo cooperation oxidative stress inhibits prevent airway allergy phagocyte receptor g2a vascular phagocyte subsets macrophages inhibit migration

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Mechanisms of failed apoptotic cell clearance by phagocyte subsets in cardiovascular disease
         description:Recent evidence in humans indicate that defective phagocytic clearance of dying cells is linked to progression of advanced atherosclerotic lesions, the precursor to atherothrombosis, ischemic heart disease, and leading cause of death in the industrialized world. During atherogenesis, apoptotic cell turnover in the vascular wall is counterbalanced by neighboring phagocytes with high clearance efficiency, thereby limiting cellularity and maintaining lesion integrity. However, as lesions mature, phagocytic removal of apoptotic cells (efferocytosis) becomes defective, leading to secondary necrosis, expansion of plaque necrotic cores, and susceptibility to rupture. Recent genetic causation studies in experimental rodents have implicated key molecular regulators of efferocytosis in atherosclerotic progression. These include MER tyrosine kinase (MERTK), milk fat globule-EGF factor 8 (MFGE8), and complement C1q. At the cellular level, atheromata are infiltrated by a heterogenous population of professional phagocytes, comprised of monocytes, differentiated macrophages, and CD11c+ dendritic-like cells. Each cell type is characterized by disparate clearance efficiencies and varying activities of key phagocytic signaling molecules. It is in this context that we outline a working model whereby plaque necrosis and destabilization is jointly promoted by (1) direct inhibition of core phagocytic signaling pathways and (2) expansion of phagocyte subsets with poor clearance capacity. Towards identifying targets for promoting efficient apoptotic cell clearance and resolving inflammation in atherosclerosis and during ischemic heart disease and post myocardial infarction, this review will discuss potential in vivo suppressors of efferocytosis at each stage of clearance and how these putative interventional targets may differentially affect uptake at the level of vascular phagocyte subsets.
         datePublished:2010-06-16T00:00:00Z
         dateModified:2010-06-16T00:00:00Z
         pageStart:1124
         pageEnd:1136
         sameAs:https://doi.org/10.1007/s10495-010-0516-6
         keywords:
            Cardiovascular disease
            Efferocytosis
            Phagocytosis
            MERTK
            Secondary necrosis
            Cancer Research
            Cell Biology
            Oncology
            Biochemistry
            general
            Virology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10495-010-0516-6/MediaObjects/10495_2010_516_Fig1_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10495-010-0516-6/MediaObjects/10495_2010_516_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10495-010-0516-6/MediaObjects/10495_2010_516_Fig3_HTML.gif
         isPartOf:
            name:Apoptosis
            issn:
               1573-675X
               1360-8185
            volumeNumber:15
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer US
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Edward B. Thorp
               affiliation:
                     name:Columbia University
                     address:
                        name:Department of Medicine, Division of Molecular Medicine, Columbia University, New York, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Mechanisms of failed apoptotic cell clearance by phagocyte subsets in cardiovascular disease
      description:Recent evidence in humans indicate that defective phagocytic clearance of dying cells is linked to progression of advanced atherosclerotic lesions, the precursor to atherothrombosis, ischemic heart disease, and leading cause of death in the industrialized world. During atherogenesis, apoptotic cell turnover in the vascular wall is counterbalanced by neighboring phagocytes with high clearance efficiency, thereby limiting cellularity and maintaining lesion integrity. However, as lesions mature, phagocytic removal of apoptotic cells (efferocytosis) becomes defective, leading to secondary necrosis, expansion of plaque necrotic cores, and susceptibility to rupture. Recent genetic causation studies in experimental rodents have implicated key molecular regulators of efferocytosis in atherosclerotic progression. These include MER tyrosine kinase (MERTK), milk fat globule-EGF factor 8 (MFGE8), and complement C1q. At the cellular level, atheromata are infiltrated by a heterogenous population of professional phagocytes, comprised of monocytes, differentiated macrophages, and CD11c+ dendritic-like cells. Each cell type is characterized by disparate clearance efficiencies and varying activities of key phagocytic signaling molecules. It is in this context that we outline a working model whereby plaque necrosis and destabilization is jointly promoted by (1) direct inhibition of core phagocytic signaling pathways and (2) expansion of phagocyte subsets with poor clearance capacity. Towards identifying targets for promoting efficient apoptotic cell clearance and resolving inflammation in atherosclerosis and during ischemic heart disease and post myocardial infarction, this review will discuss potential in vivo suppressors of efferocytosis at each stage of clearance and how these putative interventional targets may differentially affect uptake at the level of vascular phagocyte subsets.
      datePublished:2010-06-16T00:00:00Z
      dateModified:2010-06-16T00:00:00Z
      pageStart:1124
      pageEnd:1136
      sameAs:https://doi.org/10.1007/s10495-010-0516-6
      keywords:
         Cardiovascular disease
         Efferocytosis
         Phagocytosis
         MERTK
         Secondary necrosis
         Cancer Research
         Cell Biology
         Oncology
         Biochemistry
         general
         Virology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10495-010-0516-6/MediaObjects/10495_2010_516_Fig1_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10495-010-0516-6/MediaObjects/10495_2010_516_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10495-010-0516-6/MediaObjects/10495_2010_516_Fig3_HTML.gif
      isPartOf:
         name:Apoptosis
         issn:
            1573-675X
            1360-8185
         volumeNumber:15
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer US
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Edward B. Thorp
            affiliation:
                  name:Columbia University
                  address:
                     name:Department of Medicine, Division of Molecular Medicine, Columbia University, New York, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Apoptosis
      issn:
         1573-675X
         1360-8185
      volumeNumber:15
Organization:
      name:Springer US
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Columbia University
      address:
         name:Department of Medicine, Division of Molecular Medicine, Columbia University, New York, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Edward B. Thorp
      affiliation:
            name:Columbia University
            address:
               name:Department of Medicine, Division of Molecular Medicine, Columbia University, New York, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Medicine, Division of Molecular Medicine, Columbia University, New York, USA
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(380)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

4.52s.

LINK . SPRINGER . COM {}